Home › Schizophrenia › Texas
Schizophrenia clinical trials in Texas
34 studies for Schizophrenia are looking for participants at sites in Texas.
Cities in Texas
- Houston13 studies
- Austin13 studies
- Richardson9 studies
- Grand Prairie8 studies
- Dallas8 studies
- Fort Worth3 studies
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Local Institution - 0049, Austin
- Local Institution - 0194, Dallas
- Pillar Clinical Research - Richardson, Richardson
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 28, 2026 · NCT07686263A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Community Clinical Research, Inc., Austin
- Pillar Clinical Research, LLC, Richardson
RecruitingPhase 1
Ages 18 to 55 · All sexes · Updated Sep 28, 2026 · NCT07615426Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, DeSoto
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07227818NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Austin
- Neurocrine Clinical Site, DeSoto
- Neurocrine Clinical Site, Houston
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07114874Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Texas Research Group, Coppell
- PsyMed Solutions, Fort Worth
- Kaleidoscope Clinical Research, Houston
- and 3 more
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 25, 2026 · NCT06229210Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
- TG Therapeutics Investigational Trial Site, Richardson
RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Sep 23, 2026 · NCT07680946A Study of Brenipatide in Adult Participants With Schizophrenia
- Adams Clinical Dallas, DeSoto
- Re:Cognition Health - Fort Worth, Fort Worth
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Sep 22, 2026 · NCT07410507A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0149, Dallas
- VAST Clinical Research, Garland
- Local Institution - 0169, Houston
- and 2 more
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 22, 2026 · NCT07424404A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Austin
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Pillar Clinical Research, LLC, Richardson
RecruitingPhase 1
Ages 18 to 55 · All sexes · Updated Sep 17, 2026 · NCT07734493Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
- The University of Texas Health Science Center, Houston, Houston
Recruiting
Ages 22 to 65 · All sexes · Updated Sep 16, 2026 · NCT05276050A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Community Clinical Research - Cross Park Drive /ID# 272977, Austin
- Pillar Clinical Research - Richardson /ID# 275715, Richardson
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 15, 2026 · NCT0714591852-week Open Label Safety-Tolerability Study
- Adams Clinical, DeSoto
- Pillar Clinical Research, Richardson
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 9, 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- VAST Clinical Research, Garland
- Local Institution - 0120, Houston
- Local Institution - 0066, Spring
RecruitingPhase 3
Ages 13 to 17 · All sexes · Updated Sep 4, 2026 · NCT07288567A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Community Clinical Research, Austin
RecruitingPhase 1
Ages 18 to 55 · All sexes · Updated Sep 2, 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Austin
- Clinical Site, DeSoto
- Clinical Site, Richardson
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Haracec Clinical Research, El Paso
- C-Trilogy Outreach, Longview
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07101094Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Local Institution - 0016, Austin
- Local Institution - 0050, Dallas
- Local Institution - 0021, Fort Worth
- and 10 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07379827Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- BioXcel Clinical Research Site, DeSoto
RecruitingPhase 1
Ages 10 to 17 · All sexes · Updated Aug 11, 2026 · NCT05025605Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia
- The University of Texas Health Science Center at Houston, Houston
Recruiting
Ages 18 to 60 · All sexes · Updated Aug 5, 2026 · NCT07060066Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment
- The University of Texas Health Science Center at Houston, Houston
Recruiting
Ages 18 to 50 · All sexes · Updated Aug 3, 2026 · NCT02916810Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
- The University of Texas Health Science Center, Houston, Houston
Recruiting
Ages 18 to 60 · All sexes · Updated Jul 7, 2026 · NCT06345963Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)
- The University of Texas Health Science Center, Houston, Houston
Recruiting
Ages 18 to 60 · All sexes · Updated Jul 7, 2026 · NCT06961916A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Community Clinical Research, Austin
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Jun 23, 2026 · NCT07191483Deep Brain Stimulation for Psychosis
- UT Southwestern Medical Center, Dallas
Recruiting
Ages 22 to 70 · All sexes · Updated Jun 9, 2026 · NCT06257056A Study to Evaluate the Effect of KarXT on Urological Safety
- Local Institution - 0001, Austin
- InSite Clinical Research, DeSoto
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Jun 3, 2026 · NCT07221877CLOZAPINE Response in Biotype-1
- UT Southwestern Medical Center, Dallas
RecruitingPhase 4
Ages 18 to 60 · All sexes · Updated May 11, 2026 · NCT04580134Database Registry for Neural Network Biomarkers in Psychosis
- University of Texas Southwestern Medical Center, Dallas
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 60 · All sexes · Updated Apr 23, 2026 · NCT01409109Ocrelizumab for Psychosis by Autoimmunity
- Houston Methodist Research Institute, Houston
RecruitingPhase 1/2
Ages 18 to 35 · All sexes · Updated Apr 1, 2026 · NCT03971487Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Texas Southwestern Medical Center, Dallas
RecruitingObservational study
Ages 18 to 40 · All sexes · Updated Mar 10, 2026 · NCT06740383NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Austin
- Neurocrine Clinical Site, DeSoto
- Neurocrine Clinical Site, Houston
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Mar 6, 2026 · NCT06963034Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
- University of Texas at Dallas, Dallas
Recruiting
Ages 18 to 65 · All sexes · Updated Jan 23, 2026 · NCT07098169Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Austin
- Vanda Investigational Site, Houston
- Vanda Investigational Site, Irving
- and 1 more
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jan 12, 2026 · NCT06961968Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- Reviva site, Austin
- Reviva site, Richardson
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Dec 19, 2024 · NCT05184335From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.